Cancer metastasis inhibition with n-acetylneuramic acid

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 31/726 (2006.01) C07H 7/027 (2006.01)

Patent

CA 2217710

The present invention is aimed at providing an anticancer agent which can inhibit the metastasis of cancer cells when used alone. In addition, the present invention is also aimed at providing an anticancer agent which can inhibit the metastasis of cancer cells while causing a small side effect and very small toxicity even for an extended time of administration. The cancer metastasis-inhibiting anticancer agent according to the present invention is characterized by containing sialic acid, its salt, a polymer of sialic acid or a salt of the polymer as an effective ingredient.

La présente invention concerne un agent anticancéreux qui est capable d'inhiber le processus métastatique des cellules cancéreuses quand il est employé seul, qui a peu d'effets secondaires et une toxicité extrêmement faible même en cas d'administration prolongée. Cet agent comprend, comme ingrédient(s) actif(s), l'acide sialique, son sel, son polymère et/ou un sel de son polymère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cancer metastasis inhibition with n-acetylneuramic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer metastasis inhibition with n-acetylneuramic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer metastasis inhibition with n-acetylneuramic acid will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1416889

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.